Company / PP&E per Share
Ligand Pharmaceuticals, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.19
FY2025
5-year range
$0.19 / $0.92
FY2021-FY2025
Trend
-78.3%
vs FY2024
Sector context
#85 of 191
Health Care
What the data says
At $0.19, Ligand Pharmaceuticals, Inc.'s pp&e per share ranks #85 of 191 in the Health Care sector. PP&E per Share has fluctuated over the past 10 years, ranging from $0.09 in FY2016 to $0.92 in FY2023.
Based on SEC 10-K filings.
0.19 in FY2025 with a 5-year CAGR of -24.9%.
Declined from $0.92 to $0.19 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -36.9%
- 5-Year CAGR
- -24.9%
- 10-Year CAGR
- -
Sector benchmark
#85 of 191 in Health CareTop 45% of 191This company $0.19 Sector average $22.34
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 78.3% year-over-year.
- Ranks #85 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2023.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.19 | -78.3% |
| FY2024 | $0.86 | -6.4% |
| FY2023 | $0.92 | +23.7% |
| FY2022 | $0.74 | -9.3% |
| FY2021 | $0.82 | +4.6% |
| FY2020 | $0.78 | +126.6% |
| FY2019 | $0.35 | +36.2% |
| FY2018 | $0.25 | +26.1% |
| FY2017 | $0.20 | +120.9% |
| FY2016 | $0.09 | +379.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026